On-Demand Catalog

All sessions average between 60 and 90 minutes.

Modified Risk Tobacco Products (MRTPs): Navigating the MRTP Process, Post-Order Marketing, and Assessing Whether it is an Effective Tool for Risk Communication
State of FDA Medical Product Manufacturer Inspections During and After COVID-19
Premarket Tobacco Product Applications (PMTAs) and the Impending Deadline
Restarting Clinical Trials in the Wake of COVID-19
COVID-19 and Tobacco and Nicotine Products: Enforcement Disruptions, Industry Impact, and Possible Links Between Product Usage and Contracting or Worsening the Illness
What Does Current Cannabis Research Tell Us and What Are Future Prospects for Research Access?
Animal Drug Compounding: FDA’s New Guidance and Impacts on Industry
COVID-19 and Beyond: Development and Implementation of Recovery Action Plans for Medical Product Manufacturers
The Long-Awaited Biologics Transition Date Has Come: What Now?
Regulation of Over-the-Counter (OTC) Drugs: An Introduction

Filter Results